Polycythemia in the newborn.

Indian J Pediatr

Department of Pediatrics, WHO Collaborating Centre for Training and Research in Newborn Care, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.

Published: January 2008

Polycythemia is defined as a venous hematocrit of over 65%. The hematocrit in a newborn peaks at 2 hours of age and decreases gradually after that. The etiology of polycythemia is related either to intra-uterine hypoxia or secondary to fetal transfusion. The relationship between hematocrit and viscosity is almost linear till 65% and exponential thereafter. Increased viscosity of blood is associated with symptoms of hypo-perfusion. Clinical features related to polycythemia-hyperviscosity syndrome may affect all organ systems and this entity should be screened for in high-risk infants. Polycythemia may or may not be symptomatic and guidelines for management of both the types based on the current evidence are provided in the protocol.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12098-008-0010-0DOI Listing

Publication Analysis

Top Keywords

polycythemia
4
polycythemia newborn
4
newborn polycythemia
4
polycythemia defined
4
defined venous
4
venous hematocrit
4
hematocrit 65%
4
65% hematocrit
4
hematocrit newborn
4
newborn peaks
4

Similar Publications

Stroke is the second leading cause of death worldwide, according to the latest report by the World Health Organization (WHO). Intracerebral hemorrhage comprises 20-25% of the stroke in the young, with incidence rates of three to six in 100,000 people per year. One of the most common and important causes of hemorrhagic stroke in the general population is hypertension.

View Article and Find Full Text PDF

POEMS Syndrome.

Presse Med

January 2025

Department of Hematology and Cellular Therapy, National Reference Center "AL Amyloidosis and Other Monoclonal Immunoglobulin Deposit Diseases, University Hospital of Limoges, Limoges, France.

POEMS syndrome (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin changes) is a syndrome that involves a monoclonal B-cell proliferation, most often plasmacytic, and a variable number of manifestations listed or not in the acronym. These manifestations include sclerotic bone lesions, plasmacytic Castleman disease, papillary edema, peripheral edema, ascites, thrombocytosis and/or polycythemia, venous and/or arterial thrombosis, and renal, pulmonary, and cardiac impairments . Diagnosis is often delayed due to the rarity of this entity and its clinical polymorphism, which can mimic other neurological disorders.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!